Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis
出版年份 2013 全文链接
标题
Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis
作者
关键词
Levodopa, Clozapine, Olanzapine, Aripiprazole, Ziprasidone
出版物
CNS DRUGS
Volume 27, Issue 4, Pages 249-257
出版商
Springer Nature
发表日期
2013-03-26
DOI
10.1007/s40263-013-0054-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder
- (2012) Marc De Hert et al. CNS DRUGS
- Atypical Antipsychotic-Induced Weight Gain
- (2011) James L. Roerig et al. CNS DRUGS
- Antipsychotic Pharmacotherapy and Orthostatic Hypotension
- (2011) James J. Gugger CNS DRUGS
- Safety and Tolerability of Aripiprazole for Irritability in Pediatric Patients With Autistic Disorder
- (2011) Ronald N. Marcus et al. JOURNAL OF CLINICAL PSYCHIATRY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Does levodopa accelerate the pathologic process in Parkinson disease brain?
- (2011) L. Parkkinen et al. NEUROLOGY
- A Double Blind, Placebo-Controlled, Randomized Crossover Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers
- (2011) Vance L. Albaugh et al. PLoS One
- Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment
- (2010) Chen-Jee Hong et al. Pharmacogenetics and Genomics
- Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design
- (2010) Roberto Coccurello et al. PHARMACOLOGY & THERAPEUTICS
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia
- (2010) Ramachandran Padmavati et al. SCHIZOPHRENIA RESEARCH
- MTHFR and risk of metabolic syndrome in patients with schizophrenia
- (2010) Ruud van Winkel et al. SCHIZOPHRENIA RESEARCH
- Metabolic Changes Associated With Second-Generation Antipsychotic Use in Alzheimer’s Disease Patients: The CATIE-AD Study
- (2009) Ling Zheng et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of Olanzapine and Haloperidol on the Metabolic Status of Healthy Men
- (2009) Solrun Vidarsdottir et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
- (2009) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
- (2009) Gavin P Reynolds et al. PHARMACOLOGY & THERAPEUTICS
- Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease
- (2008) Giulio Scigliano et al. PARKINSONISM & RELATED DISORDERS
- No interaction of body mass index and smoking on diabetes mellitus risk in elderly women
- (2008) Michael W. Cullen et al. PREVENTIVE MEDICINE
- Differential Effects of Various Typical and Atypical Antipsychotics on Plasma Glucose and Insulin Levels in the Mouse: Evidence for the Involvement of Sympathetic Regulation
- (2008) Y. E. Savoy et al. SCHIZOPHRENIA BULLETIN
- Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin
- (2008) Hua Jin et al. SCHIZOPHRENIA RESEARCH
- Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?
- (2008) S SENGUPTA et al. SCHIZOPHRENIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started